Pregabalin for the treatment of cough
Phase 2
Recruiting
- Conditions
- Cough.Cough
- Registration Number
- IRCT20170215032587N5
- Lead Sponsor
- Ghoum University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Subacute cough (between 3 and 8 weeks) or chronic cough
Exclusion Criteria
History of asthma
History of chronic bronchitis
Pneumonia, pulmonary abscess or pulmonary tuberculosis
Smokers
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of cough attacks per day. Timepoint: 7 and 14 days after intervention. Method of measurement: Patient statement.;Number of coughs per attack. Timepoint: 7 and 14 days after intervention. Method of measurement: Patient statement.
- Secondary Outcome Measures
Name Time Method